We are live on
!
Find out more
RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$2.05B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-25.09%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.79B
AUM Growth
-$1.17B
(-39%)
Cap. Flow
-$394M
Cap. Flow
% of AUM
-22.03%
Top 10 Holdings %
Top 10 Hldgs %
23.27%
Holding
291
New
26
Increased
34
Reduced
190
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$13.4M |
| 2 |
Iovance Biotherapeutics
IOVA
|
+$12M |
| 3 |
Radware
RDWR
|
+$11.2M |
| 4 |
Karyopharm Therapeutics
KPTI
|
+$11M |
| 5 |
Progress Software
PRGS
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Performance Food Group
PFGC
|
+$19.8M |
| 2 |
Emergent Biosolutions
EBS
|
+$19.3M |
| 3 |
IMAX
IMAX
|
+$16.9M |
| 4 |
CY
Cypress Semiconductor
CY
|
+$16.8M |
| 5 |
Pool Corp
POOL
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.39% |
| 2 | Technology | 21.19% |
| 3 | Industrials | 18.35% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Marcus Corp
MCS
$920M
| – | – |
-51,146
| Closed | -$1.63M |
|
277
Myriad Genetics
MYGN
$301M
| – | – |
-351,837
| Closed | -$9.58M |
|
278
NOV
NOV
$7.44B
| – | – |
-10,238
| Closed | -$256K |
|
279
Orthofix Medical
OFIX
$422M
| – | – |
-29,869
| Closed | -$1.38M |
|
280
Oneok
OKE
$57.5B
| – | – |
-4,232
| Closed | -$320K |
|
|
281
Performance Food Group
PFGC
$17.9B
| – | – |
-384,717
| Closed | -$19.8M |
|
282
Starbucks
SBUX
$122B
| – | – |
-2,840
| Closed | -$250K |
|
283
Team
TISI
$97.8M
| – | – |
-10,828
| Closed | -$1.73M |
|
|
TPIC
284
DELISTED
TPI Composites
TPIC
| – | – |
-28,662
| Closed | -$531K |
|
285
Vanda Pharmaceuticals
VNDA
$298M
| – | – |
-60,309
| Closed | -$990K |
|
286
Cactus
WHD
$5.74B
| – | – |
-59,965
| Closed | -$2.06M |
|
287
Willis Towers Watson
WTW
$31.7B
| – | – |
-7,554
| Closed | -$1.52M |
|
288
Xcel Energy
XEL
$48.1B
| – | – |
-4,871
| Closed | -$309K |
|
|
NVRO
289
DELISTED
NEVRO CORP.
NVRO
| – | – |
-12,517
| Closed | -$1.47M |
|
|
TRHC
290
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| – | – |
-247,983
| Closed | -$12.1M |
|
|
ECOL
291
DELISTED
US Ecology, Inc.
ECOL
| – | – |
-137,860
| Closed | -$7.98M |
|
Similar funds
RC
GIM
IL
BC
SAM
AG
TA
ACP
Rice Hall James & Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Rice Hall James & Associates held 291 positions worth $1.79B, down 39% from $2.96B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Rice Hall James & Associates withdrew a net $394M in Q1 2020, closing 30 positions and reducing 190 holdings. Its most notable exit was Performance Food Group, an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Rice Hall James & Associates opened a new position in Zogenix, Inc. worth $9.13M.
- Rice Hall James & Associates's largest Q1 2020 buy was Zogenix, Inc.: 369,261 shares worth $9.13M.
- Rice Hall James & Associates added most to Radware in Q1 2020, an estimated $11.2M increase.
- Rice Hall James & Associates's biggest Q1 2020 reduction was Emergent Biosolutions, cutting an estimated $19.3M.
- Rice Hall James & Associates fully exited Performance Food Group in Q1 2020, selling an estimated $19.8M.
- Rice Hall James & Associates's ten largest holdings make up 23% of its $1.79B portfolio in Q1 2020.
- Rice Hall James & Associates opened 26 new positions and closed 30 in Q1 2020.
- Rice Hall James & Associates's portfolio value fell 39% quarter-over-quarter to $1.79B.
Based on Rice Hall James & Associates's 13F filing for Q1 2020, filed 15 May 2020.